Switch to:

Ascendis Pharma A/S EV-to-Revenue

: 184.06 (As of Today)
View and export this data going back to 2015. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Ascendis Pharma A/S's enterprise value is $4,450.19 Mil. Ascendis Pharma A/S's Revenue for the trailing twelve months (TTM) ended in Sep. 2019 was $24.18 Mil. Therefore, Ascendis Pharma A/S's EV-to-Revenue for today is 184.06.

NAS:ASND' s EV-to-Revenue Range Over the Past 10 Years
Min: 15.4   Max: 6352.5
Current: 184.07

15.4
6352.5

During the past 8 years, the highest EV-to-Revenue of Ascendis Pharma A/S was 6352.50. The lowest was 15.40. And the median was 190.20.

NAS:ASND's EV-to-Revenue is ranked lower than
89% of the 809 Companies
in the Biotechnology industry.

( Industry Median: 11.24 vs. NAS:ASND: 184.07 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2019-12-08), Ascendis Pharma A/S's stock price is $107.56. Ascendis Pharma A/S's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2019 was $0.55. Therefore, Ascendis Pharma A/S's PS Ratio for today is 194.15.


Ascendis Pharma A/S EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Ascendis Pharma A/S Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only 0.00 36.83 91.55 716.31 193.00

Ascendis Pharma A/S Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,376.89 193.00 261.71 217.95 161.86

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Ascendis Pharma A/S EV-to-Revenue Distribution

* The bar in red indicates where Ascendis Pharma A/S's EV-to-Revenue falls into.



Ascendis Pharma A/S EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Ascendis Pharma A/S's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4450.189/24.1784843669
=184.06

Ascendis Pharma A/S's current Enterprise Value is $4,450.19 Mil.
Ascendis Pharma A/S's Revenue for the trailing twelve months (TTM) ended in Sep. 2019 was 11.9624573379 (Dec. 2018 ) + 6.11751412429 (Mar. 2019 ) + 3.62824858757 (Jun. 2019 ) + 2.47026431718 (Sep. 2019 ) = $24.18 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Ascendis Pharma A/S  (NAS:ASND) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Ascendis Pharma A/S's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=107.56/0.554
=194.15

Ascendis Pharma A/S's share price for today is $107.56.
Ascendis Pharma A/S's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2019 was 0.284 (Dec. 2018 ) + 0.141 (Mar. 2019 ) + 0.077 (Jun. 2019 ) + 0.052 (Sep. 2019 ) = $0.55.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Ascendis Pharma A/S EV-to-Revenue Related Terms


Ascendis Pharma A/S EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)